2002-2022年期间结直肠腺瘤的出版趋势和热点:2022年期间结直肠腺瘤的出版趋势和热点:2022年期间结直肠腺瘤的出版趋势和热点:2022年期间结直肠腺瘤的出版趋势和热点:2022年期间结直肠腺瘤的出版趋势和热点:2022年期间
Xue Li1, Wenzheng Zhang1, Surui Yuan2
1Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Frontiers in oncology
|July 26, 2023
概括
这份图书统计分析显示,在过去20年中,全球对结直肠腺瘤 (CRA) 的研究兴趣日益增长. 关键的研究领域包括CRA的发病,预防,以及新陈代谢和微生物群的作用.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 图书统计学 图书统计学
背景情况:
- 结肠直肠腺瘤 (CRA) 的预防和治疗对于降低结肠直肠癌 (CRC) 发病率和死亡率至关重要.
- 在评估CRA广泛的研究环境时,文献计量分析的利用不足.
- 本研究提供了对过去二十年CRA研究的综合文献计量评估.
研究的目的:
- 分析目前的状况,并确定结直肠腺瘤 (CRA) 研究的前沿进展.
- 评估国家,机构,作者和期刊在CRA领域的贡献.
- 绘制过去20年中CRA研究热点和新兴趋势的地图.
主要方法:
- 在2002年至2022年期间,利用Web of Science核心集合对2,268篇出版物的图书统计分析.
- 利用CiteSpace,VOSviewer和文学计量学在线分析平台进行数据分析.
- 通过关键字和引用分析确定了关键贡献者,研究趋势和前沿主题.
主要成果:
- 全球关于CRA的出版物显示,CRA每年都在持续增长,美国是最具生产力的国家.
- 中国近年来表现出快速的出版增长和高引用影响.
- 关键的研究领域包括CRA的发病,风险因素,预防,查,治疗,新陈代谢和微生物群.
结论:
- 结肠直肠腺瘤 (CRA) 研究主要由发达国家主导,这凸显了发展中国家需要加强关注和合作的必要性.
- 巴伦·JA被认为是该领域的领先研究人员.
- 未来的研究领域包括CRA的发病,更少的侵入性诊断,化学预防和风险预测,包括肠道微生物和新陈代谢.
相关概念视频
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K